Erschienen in:
01.06.2006 | Case Report
SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody)
verfasst von:
D. J. Armstrong, M. T. McCarron, G. D. Wright
Erschienen in:
Rheumatology International
|
Ausgabe 8/2006
Einloggen, um Zugang zu erhalten
Excerpt
Rituximab (anti-CD20 monoclonal antibody) has been used successfully in the treatment of systemic lupus erythematosus (SLE) [
1,
2], but SLE-associated neurological impairment has not figured prominently in previous reports with Rituximab. We describe an SLE patient with transverse myelitis in whom treatment with cyclophosphamide had been difficult and ultimately unsuccessful, who responded dramatically to two infusions of Rituximab. …